107 listed and non-listed pharmaceutical companies recorded selling and administrative expense to sales ratio of 33.1%

According to the 2013 audit report of 107 listed and non-listed pharmaceutical companies settled in Dec which is submitted to Financial Supervisory Service, it turned out that their selling and administrative expense to sales ratio was 33.1% on average. It reduced by 1.1% than the result in 2012.

The major cause of why pharmaceutical companies reduced SG & A expenses is because drug price cut ...